Tandem Diabetes Care, Inc.
TNDM
$14.41
$0.070.49%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -14.86% | 16.50% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -14.86% | 16.50% | |||
| Cost of Revenue | -10.16% | 6.93% | |||
| Gross Profit | -18.32% | 24.70% | |||
| SG&A Expenses | -4.34% | 6.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.18% | 4.74% | |||
| Operating Income | -310.20% | 141.34% | |||
| Income Before Tax | -524.54% | 118.62% | |||
| Income Tax Expenses | -90.21% | 232.50% | |||
| Earnings from Continuing Operations | -3,362.31% | 97.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3,362.31% | 97.22% | |||
| EBIT | -310.20% | 141.34% | |||
| EBITDA | -201.10% | 182.14% | |||
| EPS Basic | -3,327.59% | 97.22% | |||
| Normalized Basic EPS | -522.33% | 120.83% | |||
| EPS Diluted | -3,327.59% | 97.22% | |||
| Normalized Diluted EPS | -522.33% | 120.83% | |||
| Average Basic Shares Outstanding | 0.56% | 0.54% | |||
| Average Diluted Shares Outstanding | 0.56% | 0.54% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||